通过干细胞疗法治疗口腔黏膜下纤维化的先进治疗策略 - Suppr | 超能文献

相似文献

1

Advanced Therapeutic Strategies for Oral Submucous Fibrosis through Stem Cell Therapy.通过干细胞疗法治疗口腔黏膜下纤维化的先进治疗策略

Stem Cell Rev Rep. 2025 Jan;21(1):287-289. doi: 10.1007/s12015-024-10801-8. Epub 2024 Oct 10.

2

Hypothesizing the therapeutic potential of mesenchymal stem cells in oral submucous fibrosis.推测间充质干细胞在口腔黏膜下纤维化中的治疗潜力。

Med Hypotheses. 2020 Nov;144:110204. doi: 10.1016/j.mehy.2020.110204. Epub 2020 Aug 24.

3

Histochemical and Immunohistochemical Analysis of Collagen Fibers and Microvascular Density in Various Grades of Oral Submucous Fibrosis.不同等级口腔黏膜下纤维化中胶原纤维和微血管密度的组织化学与免疫组织化学分析

Iran J Pathol. 2019 Spring;14(2):127-134. doi: 10.30699/IJP.14.2.127. Epub 2019 Jan 10.

4

Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation.口腔黏膜下纤维化作为一种过度愈合的伤口：对恶性转化的影响。

Recent Pat Anticancer Drug Discov. 2018;13(3):272-291. doi: 10.2174/1574892813666180227103147.

5

Physiotherapeutic Approach in Oral Submucous Fibrosis: A Systematic Review.口腔黏膜下纤维化的物理治疗方法：一项系统评价

Cureus. 2023 Nov 2;15(11):e48155. doi: 10.7759/cureus.48155. eCollection 2023 Nov.

6

Total oral reconstruction for cancers associated with advanced oral submucous fibrosis.针对与晚期口腔黏膜下纤维化相关癌症的全口口腔重建。

Ann Plast Surg. 2003 Sep;51(3):283-9. doi: 10.1097/01.SAP.0000063753.91476.05.

7

Expression and methylation of Dickkopf-1 in the pathogenesis and malignant transformation of oral submucous fibrosis.DKK-1 在口腔黏膜下纤维性变发病机制及恶性转化中的表达与甲基化。

J Oral Pathol Med. 2020 Sep;49(8):809-815. doi: 10.1111/jop.13096. Epub 2020 Aug 30.

8

Concomitant Association of Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma and Incidence of Malignant Transformation of Oral Submucous Fibrosis in a Population of Central India: A Retrospective Study.印度中部人群中口腔黏膜下纤维化与口腔鳞状细胞癌的伴发情况及口腔黏膜下纤维化的恶性转化发生率：一项回顾性研究

J Maxillofac Oral Surg. 2015 Dec;14(4):902-6. doi: 10.1007/s12663-015-0760-y. Epub 2015 Feb 25.

9

Enhanced ZEB 1 stromal expression is a marker for epithelial mesenchymal transition in oral submucous fibrosis.ZEB 1在基质中的表达增强是口腔黏膜下纤维化上皮-间质转化的一个标志物。

J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):107-111. doi: 10.1016/j.jobcr.2024.01.004. Epub 2024 Jan 19.

10

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis.PTEN和α - 平滑肌肌动蛋白在口腔黏膜下纤维化及伴发口腔黏膜下纤维化的口腔鳞状细胞癌中的表达及诊断作用

J Oral Maxillofac Res. 2021 Mar 31;12(1):e3. doi: 10.5037/jomr.2021.12103. eCollection 2021 Jan-Mar.

本文引用的文献

1

TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan.巴基斯坦嗜烟嚼烟者中 TUSC3、p53 和 p21 基因与口腔黏膜下纤维性变和口腔鳞状细胞癌发生的相关性。

BMC Oral Health. 2024 Jul 11;24(1):780. doi: 10.1186/s12903-024-04501-5.

2

Hydrogels for Oral Tissue Engineering: Challenges and Opportunities.水凝胶用于口腔组织工程：挑战与机遇。

Molecules. 2023 May 7;28(9):3946. doi: 10.3390/molecules28093946.

3

Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.